Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients based on plasma Epstein–Barr virus DNA level after induction chemotherapy

Purpose: This study aimed to elucidate the optimal cumulative cisplatin dose (CCD) for concurrent chemoradiotherapy (CCRT) according to the post-induction chemotherapy (IC) plasma Epstein–Barr virus (EBV) DNA level. Results: EBV DNA was detected and undetected in 179 and 370 patients, respectively....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sai-Lan, Sun, Xue-Song, Liu, Li-Ting, Sun, Rui, Luo, Dong-Hua, Chen, Qiu-Yan, Lin, Huan-Xin, Yuan, Li, Tang, Lin-Quan, Guo, Ling, Mai, Hai-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138583/
https://www.ncbi.nlm.nih.gov/pubmed/32221045
http://dx.doi.org/10.18632/aging.102920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138583/
https://www.ncbi.nlm.nih.gov/pubmed/32221045
http://dx.doi.org/10.18632/aging.102920

Ejemplares similares